Hefei Life Science Research Institute

Hefei Life Science Research Institute is the primary research and development subsidiary of Anhui Anke Biotechnology (Group) Co., Ltd. (Ankebio), a prominent Chinese biopharmaceutical company. The institute focuses on the innovation and development of high-end biologics, including recombinant proteins, monoclonal antibodies, and advanced cell therapies such as CAR-T. It has been instrumental in bringing several key products to market, most notably recombinant human growth hormone and interferon alpha-2b. Located in the Hefei High-tech Zone, the institute operates state-of-the-art laboratories dedicated to molecular biology, protein engineering, and pilot-scale manufacturing. Its research efforts primarily target therapeutic areas such as oncology, endocrinology, and infectious diseases, serving as the core engine for Ankebio's long-term product pipeline.